Labor Senators' Dissenting Report
1.1
Labor Senators oppose the abolition of the schedule 2—seafarer tax
offset and the reduction in the schedule 3—rates of the R&D tax incentive.
Seafarer Tax Offset
1.2
Labor Senators oppose the abolition of this measure, rejecting the
Abbott Government's attempt to remove the measures Labor introduced to
revitalise Australian shipping.
1.3
The object of this offset is to stimulate opportunities for Australian
seafarers to be employed or engaged on overseas voyages, and acquire maritime
skills, benefiting employers of Australian seafarers.
1.4
Labor Senators emphasize that there were no submissions to the inquiry supporting
the abolition of the seafarer tax offset. This includes diverse stakeholders such
as the Australian Shipowners Association, Shipping Australia, and the Maritime
Union of Australia.
1.5
The Government is attempting to abolish the seafarer tax offset less
than two years after it was introduced, without giving it an opportunity to
expand Australia's maritime skills base.
1.6
This tax initiative was one of several that arose from the lengthy
industry consultations that led to Labor's Shipping package.
1.7
It is in Australia's national and security interest to revitalise the
Australian shipping industry. We are an island nation; one-tenth of the world's
trade goes to or from Australia, the fourth largest shipping task in the world.
1.8
Labor Senators note the evidence provided opposing the repeal of this
offset by the Australian Shipowners Association to this inquiry:
The Seafarers Tax Offset was a key element of the 2012
reforms which helped to reduce the operating costs of Australian vessels,
increased the competitiveness of Australian shipping and provided significant
opportunity for employment of Australians in international trades...the impact
[of abolition] is severe with regard to future opportunity.[1]
R&D tax incentive
1.9
In advanced industrial economies, innovation is the principle driver of
increases in productivity. Firms that innovate are more competitive and can
sustain more high-skilled, high-paid jobs.
1.10
Tax incentives are one of the most effective tools available to
government for stimulating and attracting investment in innovation. This
investment, in turn, is critical to developing dynamic and highly productive
industries, able to compete at the top of the global value chain.
1.11
In the 1980s Labor introduced the R&D tax concession, making
Australia one of the first countries in the world to foster innovation through
the taxation system.
1.12
The Labor government updated the scheme in 2011, and the positive effect
of the new measure was immediate. Data from the Department of Industry shows
that 'There has been significant growth in the number of new firms undertaking
R&D under this programme, with a 49 per cent increase in 2011–12 and a
further increase of at least 9 per cent in 2012–13.'
1.13
The R&D Tax Incentive was a landmark reform, building on Labor's
record of investment in innovation and R&D. Today, though still relatively
new, it is an important feature of Australia's innovation policy framework and
encourages companies to invest in R&D.
1.14
The current proposal to reduce the rate of the R&D Tax Incentive by
1.5 per cent is supposed to be consistent with the Government's pledge to cut
the company tax rate from 1 July 2015 by maintaining the relative value of the
offsets.
1.15
The R&D Tax Incentive was intended to be independent of the company
tax rate, ensuring the level of benefit provided remains constant and provides
certainty for R&D investors, regardless of any fluctuations in the company
tax rate.
1.16
This was clarified in Powering Ideas: the Labor Government's
Innovation Agenda for the 21st Century, which states the R&D Tax
Incentive 'increases certainty by uncoupling the level of R&D support from
the corporate tax rate' (2008, p. 47). This point was acknowledged by the
Department of Industry in response to a written question from Budget Estimates
hearings held from 2 to 3 June 2014:
Under the R&D Tax Incentive the rates are independent of
the company tax rate, therefore the level of benefit provided remains constant,
and therefore certain, regardless of changes to the company tax rate.
1.17
Labor Senators note that 19 of the 23 public submissions made to the
inquiry into Tax and Superannuation Laws Amendment (2014 Measures No. 5) Bill 2014,
were responding directly to provisions in the bill that seek to reduce the
rates of the tax offset. Each of these submissions is critical of the
government's proposed changes.
1.18
The most pressing concern for stakeholders is the increasing uncertainty
this measure will create for the business community, by actively discouraging
investment in R&D. This is precisely the situation the Labor Government was
trying to avoid when it introduced the R&D Tax Incentive, making it
independent of the company tax rate.
1.19
As noted by KPMG:
When the R&D tax incentive was first introduced, it was
the Government's intention that providing a tax offset rather than a deduction
would mean that changes in the corporate tax rate would not impact the R&D
incentive. That is, companies had the certainty that they would continue to get
a 40 per cent or 45 per cent offset regardless of the corporate tax rate.[2]
1.20
Likewise, BDO stated that:
...the key driver to change the delivery of the incentive from
additional deductions to a tax offset was for the very purpose of decoupling
the incentive from the corporate tax rate thereby improving investment
certainty.[3]
1.21
Ensuring certainty and business confidence is especially important in
R&D intensive sectors, such as the life sciences. As noted in the
submission from AusBiotech:
Constant threats and tweaks to the R&D tax incentive are
unsettling for business and undermine business and investor confidence at a
time when Australia can least afford it.[4]
1.22
Similarly, BioMelbourne Network notes that 'Certainty around the
maintenance of this initiative is critical to Australian businesses and the
Australian economy' and that:
The proposed reduction in the R&D tax offset will have a
real negative impact on the ability of BioMelbourne Network members to develop
and deliver health products and services to the Australian public.[5]
1.23
The uncertainty and policy inconsistency created by the proposed change
cannot be overstated, and concerns about the impact of this change on R&D
investment in Australia are repeated in almost all submissions to the committee.
1.24
As noted by Ernst & Young, 'This type of inconsistency can
discourage R&D investment by both small and large companies within
Australia;' and as noted by KPMG, 'The rate reduction limits companies' ability
to plan their long term R&D investments' and 'Through its conduct, the
Government is actively dissuading companies from doing R&D in Australia.'
1.25
Labor Senators also note that the decrease in the R&D tax rate will
especially harm small research-intensive firms that are generating little
profit. For these companies, the reduction in the R&D rate will not be
offset by an associated reduction in the company tax rate, as they are not
likely to be paying tax.
1.26
As noted by BioMelbourne Network:
The amendment will also have a disproportionate impact on
companies operating with a tax loss and currently receive the R&D tax
incentive as a refund. This impacts the smallest and most vulnerable companies,
such as start-ups, 'spin-outs' and SMEs, who make up a majority of companies in
Australia's pharmaceutical and medical technology sectors.
1.27
This point is echoed by PricewaterhouseCoopers, which stated that 'some
companies will be impacted on a permanent basis rather than for just one income
year.'[6]
1.28
Labor Senators also note that the proposed tax changes precede the
release of a wide-ranging tax white paper, further adding to the uncertainty
surrounding the future of the R&D Tax Incentive.
Senator Sam
Dastyari
Deputy Chair
Senator Chris Ketter
Senator for Queensland
Senator the Hon Kim Carr
Senator for Victoria
Navigation: Previous Page | Contents | Next Page